Molecular genetic alterations in superficial and locally advanced human bladder cancer - PubMed (original) (raw)
. 1991 Oct 1;51(19):5405-9.
Affiliations
- PMID: 1680549
Molecular genetic alterations in superficial and locally advanced human bladder cancer
J C Presti Jr et al. Cancer Res. 1991.
Abstract
We attempted to define the role of tumor suppressor genes in the pathogenesis of human bladder cancer through a combined molecular genetic and immunohistochemical approach. Thirty-four bladder tumors (1 Pis, 6 Pa, 5 P1, 3 P3a, 18 P3b, 1 P4; 8 low grade and 26 high grade tumors) have been analyzed. Restriction fragment length polymorphism analysis directed at 5 suspected or established tumor suppressor gene regions (3p21-25, 11p15, 13q14, 17p11-13, and 18q21) was combined with immunohistochemical using Rb-PMG3-245 monoclonal antibody directed at the retinoblastoma (Rb) gene product. Tumor grade correlated with deletions of 3p (P = 0.004) and 17p (P = 0.063). Tumor stage correlated with deletions of 3p (P = 0.010), 17p (P = 0.015) and altered Rb expression (P = 0.054). Vascular invasion correlated only with deletions of 17p (P = 0.038). No marker correlated with positive lymph nodes. Our results suggest that altered Rb expression occurs in all grades and stages of bladder cancer but is more commonly associated with invasive tumors. Genetic alterations of 3p, 11p, 17p, and 18q are rare events in low grade, superficial tumors, whereas they are more common in high grade and invasive bladder cancer. The role of these genetic alterations in the prognosis of bladder cancer will require additional follow-up and further studies.
Similar articles
- Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer.
Dalbagni G, Presti JC Jr, Reuter VE, Zhang ZF, Sarkis AS, Fair WR, Cordon-Cardo C. Dalbagni G, et al. Diagn Mol Pathol. 1993 Mar;2(1):4-13. Diagn Mol Pathol. 1993. PMID: 7904525 - Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
Gerdes H, Chen Q, Elahi AH, Sircar A, Goldberg E, Winawer D, Urmacher C, Winawer SJ, Jhanwar SC. Gerdes H, et al. Anticancer Res. 1995 Jan-Feb;15(1):13-24. Anticancer Res. 1995. PMID: 7733622 - Role of chromosome 9 in human bladder cancer.
Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH 3rd, Gonzalez-Zulueta M, Nichols PW, Skinner DG, Jones PA. Miyao N, et al. Cancer Res. 1993 Sep 1;53(17):4066-70. Cancer Res. 1993. PMID: 8358736 - Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C. Cordon-Cardo C. Scand J Urol Nephrol Suppl. 2008 Sep;(218):154-65. doi: 10.1080/03008880802291915. Scand J Urol Nephrol Suppl. 2008. PMID: 18815930 Review. - [Multiple genetic alterations in primary breast cancer].
Nakamura Y, Sato T. Nakamura Y, et al. Nihon Rinsho. 1991 Apr;49(4):975-82. Nihon Rinsho. 1991. PMID: 1677053 Review. Japanese. No abstract available.
Cited by
- A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells.
Jia AY, Castillo-Martin M, Domingo-Domenech J, Bonal DM, Sánchez-Carbayo M, Silva JM, Cordon-Cardo C. Jia AY, et al. Am J Pathol. 2013 Apr;182(4):1171-9. doi: 10.1016/j.ajpath.2013.01.006. Epub 2013 Feb 12. Am J Pathol. 2013. PMID: 23410519 Free PMC article. - Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis.
Nishikawa M, Oshitani N, Matsumoto T, Nishigami T, Arakawa T, Inoue M. Nishikawa M, et al. Br J Cancer. 2005 Aug 8;93(3):331-7. doi: 10.1038/sj.bjc.6602664. Br J Cancer. 2005. PMID: 15956973 Free PMC article. - Clinical states model for biomarkers in bladder cancer.
Apolo AB, Milowsky M, Bajorin DF. Apolo AB, et al. Future Oncol. 2009 Sep;5(7):977-92. doi: 10.2217/fon.09.57. Future Oncol. 2009. PMID: 19792967 Free PMC article. Review. - Isolation and characterization of a novel human bladder cancer cell line: BK10.
Roberson KM, Yancey DR, Padilla-Nash H, Edwards DW, Nash W, Jacobs S, Padilla GM, Larchian WA, Robertson CN. Roberson KM, et al. In Vitro Cell Dev Biol Anim. 1998 Jul-Aug;34(7):537-44. doi: 10.1007/s11626-998-0113-y. In Vitro Cell Dev Biol Anim. 1998. PMID: 9719413 - Overcoming cellular senescence in human cancer pathogenesis.
Yeager TR, DeVries S, Jarrard DF, Kao C, Nakada SY, Moon TD, Bruskewitz R, Stadler WM, Meisner LF, Gilchrist KW, Newton MA, Waldman FM, Reznikoff CA. Yeager TR, et al. Genes Dev. 1998 Jan 15;12(2):163-74. doi: 10.1101/gad.12.2.163. Genes Dev. 1998. PMID: 9436977 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical